SK Chemical's pharmaceutical business, which is to be sold, has reached its sales peak. The company's pharmaceuticals and new drugs under contract have demonstrated stable growth in the prescription market.

On the 8th, SK Chemical reported that its pharmaceutical business generated sales of 376.1 won last year, representing an increase of 19.9% YoY. The operating profit for the same period was 31.5 billion won, showing a slight decrease of 6.3% YoY.

Last year, the sales of SK Chemical’s pharmaceutical business recorded the highest amount in its history. In Q4 of last year, SK Chemical’s pharmaceutical business generated sales of 105.8 billion won, marking an increase of 32.4% YoY. As a re